Filing Flows › Zimmer Biomet Holdings (ZBH) › Q2 2026 › vs Q2 2025
Zimmer Biomet Holdings (ZBH) Q2 2026 vs Q2 2025 (year over year)
Zimmer Biomet Holdings's revenue rose $99.7M (+5%) from $2.1B in Q2 2025 to $2.2B in Q2 2026. The biggest changes: SET +$35.4M (+6%); Technology and Data Bone Cement and Surgical +$34.8M (+21%); Hips +$26.6M (+5%). Operating margin 15.0% against 14.4% (+0.5 pts).
Zimmer Biomet Holdings, Q2 2026: revenue $2.2B (+5% year over year), operating margin 15.0%, net earnings $200M, operating cash flow $448M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Operating margin | 15.0% | 14.4% | +0.5 pts |
| Net margin | 9.2% | 7.4% | +1.8 pts |
| Free cash flow margin | 14.2% | 11.9% | +2.2 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Knees | $829M | $826M | $2.9M | +0.4% |
| SET | $586M | $551M | $35.4M | +6% |
| Hips | $563M | $536M | $26.6M | +5% |
| Technology and Data Bone Cement and Surgical | $199M | $165M | $34.8M | +21% |
| Revenue | $2.2B | $2.1B | $99.7M | +5% |
| Operating profit | $326M | $300M | $26.1M | +9% |
| Costs & expenses | $1.9B | $1.8B | $73.6M | +4% |
| Pre-tax earnings | $255M | $225M | $30.5M | +14% |
| Other expense, net | $71.0M | $75.4M | −$4.4M | -6% |
| Cost of revenue | $636M | $592M | $43.3M | +7% |
| Research & development | $105M | $113M | −$8.5M | -8% |
| SG&A | $899M | $815M | $84.5M | +10% |
| Other operating costs | $211M | $257M | −$45.7M | -18% |
| Net earnings | $200M | $153M | $46.2M | +30% |
| Income tax | $55.5M | $71.2M | −$15.7M | -22% |
| Depreciation & amortization | $271M | $272M | −$1.0M | -0.4% |
| Share-based compensation | $24.6M | $21.2M | $3.4M | +16% |
| Working capital & other | $47.2M | $68.2M | −$21.0M | -31% |
| Operating cash flow | $448M | $378M | $69.6M | +18% |
| Free cash flow (company-reported) | $308M | $248M | $60.5M | +24% |
| Itions to instruments | $85.4M | $80.5M | $4.9M | +6% |
| Itions to other property, plant and equipment | $54.2M | $50.0M | $4.2M | +8% |
Questions
How much did Zimmer Biomet Holdings's revenue grow year over year in Q2 2026?
Zimmer Biomet Holdings's revenue rose $99.7M (+5%) from $2.1B in Q2 2025 to $2.2B in Q2 2026.
What drove Zimmer Biomet Holdings's revenue change in Q2 2026?
SET +$35.4M (+6%); Technology and Data Bone Cement and Surgical +$34.8M (+21%); Hips +$26.6M (+5%).